Literature DB >> 25699140

Diphenylpyrazoles as replication protein a inhibitors.

Alex G Waterson1, J Phillip Kennedy1, James D Patrone1, Nicholas F Pelz1, Michael D Feldkamp1, Andreas O Frank1, Bhavatarini Vangamudi1, Elaine M Souza-Fagundes1, Olivia W Rossanese1, Walter J Chazin1, Stephen W Fesik1.   

Abstract

Replication Protein A is the primary eukaryotic ssDNA binding protein that has a central role in initiating the cellular response to DNA damage. RPA recruits multiple proteins to sites of DNA damage via the N-terminal domain of the 70 kDa subunit (RPA70N). Here we describe the optimization of a diphenylpyrazole carboxylic acid series of inhibitors of these RPA-protein interactions. We evaluated substituents on the aromatic rings as well as the type and geometry of the linkers used to combine fragments, ultimately leading to submicromolar inhibitors of RPA70N protein-protein interactions.

Entities:  

Keywords:  Replication protein A; fragment-based discovery; medicinal chemistry

Year:  2014        PMID: 25699140      PMCID: PMC4329576          DOI: 10.1021/ml5003629

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  12 in total

Review 1.  ATR: an essential regulator of genome integrity.

Authors:  Karlene A Cimprich; David Cortez
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-02       Impact factor: 94.444

2.  Compound Design by Fragment-Linking.

Authors:  Osamu Ichihara; John Barker; Richard J Law; Mark Whittaker
Journal:  Mol Inform       Date:  2011-04-06       Impact factor: 3.353

3.  ATR and ATRIP: partners in checkpoint signaling.

Authors:  D Cortez; S Guntuku; J Qin; S J Elledge
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

4.  A high-throughput fluorescence polarization anisotropy assay for the 70N domain of replication protein A.

Authors:  Elaine M Souza-Fagundes; Andreas O Frank; Michael D Feldkamp; Daniel C Dorset; Walter J Chazin; Olivia W Rossanese; Edward T Olejniczak; Stephen W Fesik
Journal:  Anal Biochem       Date:  2011-12-01       Impact factor: 3.365

5.  Discovery of Protein-Protein Interaction Inhibitors of Replication Protein A.

Authors:  James D Patrone; J Phillip Kennedy; Andreas O Frank; Michael D Feldkamp; Bhavatarini Vangamudi; Nicholas F Pelz; Olivia W Rossanese; Alex G Waterson; Walter J Chazin; Stephen W Fesik
Journal:  ACS Med Chem Lett       Date:  2013-07-11       Impact factor: 4.345

6.  The basic cleft of RPA70N binds multiple checkpoint proteins, including RAD9, to regulate ATR signaling.

Authors:  Xin Xu; Sivaraja Vaithiyalingam; Gloria G Glick; Daniel A Mordes; Walter J Chazin; David Cortez
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

7.  RPA inhibition increases replication stress and suppresses tumor growth.

Authors:  Jason G Glanzer; Shengqin Liu; Ling Wang; Adam Mosel; Aimin Peng; Greg G Oakley
Journal:  Cancer Res       Date:  2014-07-28       Impact factor: 12.701

Review 8.  A dynamic model for replication protein A (RPA) function in DNA processing pathways.

Authors:  Ellen Fanning; Vitaly Klimovich; Andrew R Nager
Journal:  Nucleic Acids Res       Date:  2006-08-25       Impact factor: 16.971

9.  Discovery of a potent inhibitor of replication protein a protein-protein interactions using a fragment-linking approach.

Authors:  Andreas O Frank; Michael D Feldkamp; J Phillip Kennedy; Alex G Waterson; Nicholas F Pelz; James D Patrone; Bhavatarini Vangamudi; DeMarco V Camper; Olivia W Rossanese; Walter J Chazin; Stephen W Fesik
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

10.  Discovery of a potent stapled helix peptide that binds to the 70N domain of replication protein A.

Authors:  Andreas O Frank; Bhavatarini Vangamudi; Michael D Feldkamp; Elaine M Souza-Fagundes; Jessica W Luzwick; David Cortez; Edward T Olejniczak; Alex G Waterson; Olivia W Rossanese; Walter J Chazin; Stephen W Fesik
Journal:  J Med Chem       Date:  2014-02-19       Impact factor: 7.446

View more
  5 in total

1.  Structure-Guided Optimization of Replication Protein A (RPA)-DNA Interaction Inhibitors.

Authors:  Navnath S Gavande; Pamela S VanderVere-Carozza; Katherine S Pawelczak; Tyler L Vernon; Matthew R Jordan; John J Turchi
Journal:  ACS Med Chem Lett       Date:  2020-01-02       Impact factor: 4.345

2.  Targeting Allostery with Avatars to Design Inhibitors Assessed by Cell Activity: Dissecting MRE11 Endo- and Exonuclease Activities.

Authors:  Davide Moiani; Daryl A Ronato; Chris A Brosey; Andrew S Arvai; Aleem Syed; Jean-Yves Masson; Elena Petricci; John A Tainer
Journal:  Methods Enzymol       Date:  2018-02-22       Impact factor: 1.600

Review 3.  DNA repair targeted therapy: The past or future of cancer treatment?

Authors:  Navnath S Gavande; Pamela S VanderVere-Carozza; Hilary D Hinshaw; Shadia I Jalal; Catherine R Sears; Katherine S Pawelczak; John J Turchi
Journal:  Pharmacol Ther       Date:  2016-02-16       Impact factor: 12.310

Review 4.  Recent advancements in the discovery of protein-protein interaction inhibitors of replication protein A.

Authors:  James D Patrone; Alex G Waterson; Stephen W Fesik
Journal:  Medchemcomm       Date:  2016-11-04       Impact factor: 3.597

Review 5.  OB-Folds and Genome Maintenance: Targeting Protein-DNA Interactions for Cancer Therapy.

Authors:  Sui Par; Sofia Vaides; Pamela S VanderVere-Carozza; Katherine S Pawelczak; Jason Stewart; John J Turchi
Journal:  Cancers (Basel)       Date:  2021-07-03       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.